In this IPD meta-analysis, metformin was not associated with a reduction in GDM, but was associated with an increase in gestational age at delivery, and Gastrointestinal side effects were more commonly reported with metformin.
A. Mousa, T. Løvvik, S. Carlsen et al.· NEJM Evidence· 0 citations
It is found that lifestyle interventions were associated with improved menstrual regularity and metabolic outcomes in women with PMOS, suggesting complementary benefits as no single intervention showed overall superiority.
The rationale for the PCOS-to-PMOS rename is discussed, evidence linking PMOS with adverse pregnancy and offspring outcomes is reviewed, and practical implications for obstetric and gynecologic care are outlined.
M. B. Khomami, K. Hoeger, H. Huddleston et al.· American Journal of Obstetri...· 0 citations
Polyendocrine metabolic ovarian syndrome (PMOS) affects 8-13% of women across the lifespan. Those with PMOS have reduced quality of life and increased risk of co-morbidities including elevated weight, eating disorders, gestational diabetes, type 2 diabetes and cardiovascular disease. PMOS is a major population in clini...
Donna Vine, Lisa J. Moran, H. Teede et al.· Advances in Nutrition· 0 citations
In unselected populations, the majority of women with PCOS exhibit a normal BMI, in contrast to clinic-based cohorts, where obesity is markedly overrepresented, which indicates that longitudinal, population-based studies integrating multi-omic data are essential for unraveling BMI-related heterogeneity.
A. Bizuneh, C. Tay, Arul Earnest et al.· European Journal of Endocrin...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.